Media pushes success of GSK malaria vaccine while ignoring deadly side effects

NewsVoice is an online news and debate channel that started in 2011. The purpose is to publish independent news, debate articles and comments as well as analyzes.
publicerad 23 oktober 2011
- News@NewsVoice
Stickmygga (Culiseta longiareolata). Foto: Alvesgaspar. Licens: CC BY-SA 3.0, Wikimedia Commons

NATURAL NEWS. “Mainstream media is excited over GlaxoSmithKline’s latest offering, a malaria trial vaccine that the company claims can cut the risk of clinical and severe malaria in children by 56% and 47%, respectively. But what GSK and the media do not report are the vaccine’s deadly side effects.

Bill & Melinda Gates Foundation suggest that children who receive three doses will have additional protection against malaria when used in conjunction with other disease control methods. But the findings also show that vaccinated children are at a high risk of serious injury or death as well.”

Learn more

ArcanumSkolan 2024

Du kan stötta Newsvoice via MediaLinq

Tags: vaccin